• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇化腺病毒:从鼠到人。

PEGylated Adenoviruses: From Mice to Monkeys.

机构信息

Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.

Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA.

出版信息

Viruses. 2010 Feb;2(2):468-502. doi: 10.3390/v2020468. Epub 2010 Feb 1.

DOI:10.3390/v2020468
PMID:21994645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3185605/
Abstract

Covalent modification with polyethylene glycol (PEG), a non-toxic polymer used in food, cosmetic and pharmaceutical preparations for over 60 years, can profoundly influence the pharmacokinetic, pharmacologic and toxciologic profile of protein and peptide-based therapeutics. This review summarizes the history of PEGylation and PEG chemistry and highlights the value of this technology in the context of the design and development of recombinant viruses for gene transfer, vaccination and diagnostic purposes. Specific emphasis is placed on the application of this technology to the adenovirus, the most potent viral vector with the most highly characterized toxicity profile to date, in several animal models.

摘要

聚乙二醇(PEG)的共价修饰,一种在食品、化妆品和药物制剂中使用了超过 60 年的无毒聚合物,可以显著影响蛋白和肽类治疗药物的药代动力学、药理学和毒理学特性。这篇综述总结了 PEG 化和 PEG 化学的历史,并强调了该技术在设计和开发用于基因转移、疫苗接种和诊断目的的重组病毒方面的价值。特别强调了该技术在几种动物模型中对腺病毒的应用,腺病毒是迄今为止最有效的病毒载体,其毒性特征也得到了最充分的描述。

相似文献

1
PEGylated Adenoviruses: From Mice to Monkeys.聚乙二醇化腺病毒:从鼠到人。
Viruses. 2010 Feb;2(2):468-502. doi: 10.3390/v2020468. Epub 2010 Feb 1.
2
PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.腺病毒的聚乙二醇化修饰在体内外均保留感染性并免受中和抗体的影响。
Hum Gene Ther. 1999 May 20;10(8):1349-58. doi: 10.1089/10430349950018021.
3
PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.缺失E1区的腺病毒载体经聚乙二醇化修饰后,再次给药至肝脏时可实现显著的基因表达。
Hum Gene Ther. 2002 Oct 10;13(15):1887-900. doi: 10.1089/104303402760372972.
4
Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.完全脱靶的聚乙二醇包被腺病毒载体是有效的基因疫苗,且能避开预先存在的抗腺病毒抗体。
Mol Ther. 2008 Jan;16(1):154-62. doi: 10.1038/sj.mt.6300306. Epub 2007 Sep 11.
5
[Induction of Anti-PEG Immune Responses by PEGylation of Proteins].[蛋白质聚乙二醇化诱导抗聚乙二醇免疫反应]
Yakugaku Zasshi. 2020;140(2):163-169. doi: 10.1248/yakushi.19-00187-5.
6
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.生物制药的聚乙二醇化修饰:已批准药物的化学及非临床安全性信息综述
J Pharm Sci. 2016 Feb;105(2):460-475. doi: 10.1016/j.xphs.2015.11.015.
7
Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.评估聚乙二醇对第一代腺病毒载体和辅助依赖型腺病毒载体的修饰以降低先天性免疫反应。
Mol Ther. 2005 Jan;11(1):66-79. doi: 10.1016/j.ymthe.2004.09.015.
8
Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses.用聚乙二醇屏蔽腺病毒载体对载体特异性免疫反应和疫苗介导的免疫反应的影响。
Hum Gene Ther. 2008 Dec;19(12):1369-82. doi: 10.1089/hum.2008.091.
9
Optimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancer.优化的聚乙二醇化腺病毒载体降低了针对腺病毒的抗载体体液免疫应答,并诱导了对转移性肺癌的治疗效果。
Biol Pharm Bull. 2010;33(9):1540-4. doi: 10.1248/bpb.33.1540.
10
Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.聚乙二醇化干扰素α-2b的结构、生物学特性及治疗意义
Curr Pharm Des. 2002;8(24):2139-57. doi: 10.2174/1381612023393242.

引用本文的文献

1
Striving for Uniformity: A Review on Advances and Challenges To Achieve Uniform Polyethylene Glycol.追求一致性:关于实现均匀聚乙二醇的进展与挑战的综述
Org Process Res Dev. 2024 Apr 1;28(4):860-890. doi: 10.1021/acs.oprd.3c00428. eCollection 2024 Apr 19.
2
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses.通过全身递送聚合物复合溶瘤腺病毒进行肿瘤靶向治疗的挑战与进展。
Cancer Gene Ther. 2022 Oct;29(10):1321-1331. doi: 10.1038/s41417-022-00469-y. Epub 2022 Apr 20.
3
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus.

本文引用的文献

1
The influence of innate and pre-existing immunity on adenovirus therapy.先天免疫和固有免疫对腺病毒治疗的影响。
J Cell Biochem. 2009 Nov 1;108(4):778-90. doi: 10.1002/jcb.22328.
2
The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.聚乙二醇化脂质体用于延长组织型纤溶酶原激活剂的循环寿命。
Biomaterials. 2009 Oct;30(29):5751-6. doi: 10.1016/j.biomaterials.2009.07.021. Epub 2009 Aug 4.
3
Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis.
聚合物隐身及黏蛋白-1重靶向以增强溶瘤痘苗病毒的药代动力学
Mol Ther Oncolytics. 2021 Mar 17;21:47-61. doi: 10.1016/j.omto.2021.03.011. eCollection 2021 Jun 25.
4
Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor.细胞外囊泡模拟封装改善了柯萨奇病毒和腺病毒受体低表达肿瘤中的溶瘤病毒免疫疗法。
Front Bioeng Biotechnol. 2020 Sep 16;8:574007. doi: 10.3389/fbioe.2020.574007. eCollection 2020.
5
Protein cages and virus-like particles: from fundamental insight to biomimetic therapeutics.蛋白质笼和病毒样颗粒:从基础研究到仿生治疗学。
Biomater Sci. 2020 May 19;8(10):2771-2777. doi: 10.1039/d0bm00159g.
6
Innate immunity to adenovirus: lessons from mice.先天性抗腺病毒免疫:来自小鼠的启示。
FEBS Lett. 2019 Dec;593(24):3461-3483. doi: 10.1002/1873-3468.13696. Epub 2019 Dec 8.
7
Biopolymers augment viral vectors based gene delivery.生物聚合物增强基于病毒载体的基因传递。
J Biosci. 2019 Sep;44(4).
8
Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.溶瘤病毒对肿瘤微环境的免疫转换:细小病毒 H-1PV 案例研究。
Front Immunol. 2019 Aug 7;10:1848. doi: 10.3389/fimmu.2019.01848. eCollection 2019.
9
Engineering Human Epidermal Growth Receptor 2-Targeting Hepatitis B Virus Core Nanoparticles for siRNA Delivery and .工程化靶向人表皮生长因子受体2的乙肝病毒核心纳米颗粒用于小干扰RNA递送及……(原文此处不完整)
ACS Appl Nano Mater. 2018 Jul 27;1(7):3269-3282. doi: 10.1021/acsanm.8b00480. Epub 2018 Jun 20.
10
Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.物理、化学和合成病毒学:将病毒重新编程为可控的纳米器件。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 May;11(3):e1545. doi: 10.1002/wnan.1545. Epub 2018 Nov 8.
携带肿瘤特异性启动子的聚乙二醇化腺病毒载体全身给药在转移的小鼠模型中有效。
Gene Ther. 2009 Dec;16(12):1395-404. doi: 10.1038/gt.2009.95.
4
New insights on adenovirus as vaccine vectors.腺病毒作为疫苗载体的新见解。
Mol Ther. 2009 Aug;17(8):1333-9. doi: 10.1038/mt.2009.130. Epub 2009 Jun 9.
5
Strategies to overcome host immunity to adenovirus vectors in vaccine development.疫苗研发中克服宿主对腺病毒载体免疫的策略。
Expert Rev Vaccines. 2009 Jun;8(6):761-77. doi: 10.1586/erv.09.29.
6
Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.用高分子量聚乙二醇进行化学修饰可降低肝细胞的转导,并提高静脉注射溶瘤腺病毒的疗效。
Hum Gene Ther. 2009 Sep;20(9):975-88. doi: 10.1089/hum.2009.028.
7
Rapid modification of retroviruses using lipid conjugates.使用脂质共轭物对逆转录病毒进行快速修饰。
Nanotechnology. 2009 Feb 11;20(6):065103. doi: 10.1088/0957-4484/20/6/065103. Epub 2009 Jan 14.
8
PEG-modified biopharmaceuticals.聚乙二醇修饰的生物制药
Expert Opin Drug Deliv. 2009 Jan;6(1):1-16. doi: 10.1517/17425240802650568.
9
PEGylation: an approach for drug delivery. A review.聚乙二醇化:一种药物递送方法。综述。
Crit Rev Ther Drug Carrier Syst. 2008;25(5):403-47. doi: 10.1615/critrevtherdrugcarriersyst.v25.i5.10.
10
Nonviral vectors for gene delivery.用于基因递送的非病毒载体。
Chem Rev. 2009 Feb;109(2):259-302. doi: 10.1021/cr800409e.